These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 19552620

  • 41. Direct cost burden among insured US employees with migraine.
    Hawkins K, Wang S, Rupnow M.
    Headache; 2008 Apr; 48(4):553-63. PubMed ID: 18070057
    [Abstract] [Full Text] [Related]

  • 42. Myelodysplastic syndrome incidence, transfusion dependence, health care use, and complications: an Australian population-based study 1998 to 2008.
    McQuilten ZK, Polizzotto MN, Wood EM, Sundararajan V.
    Transfusion; 2013 Aug; 53(8):1714-21. PubMed ID: 23305556
    [Abstract] [Full Text] [Related]

  • 43. Cost of patients with primary open-angle glaucoma: a retrospective study of commercial insurance claims data.
    Lee PP, Levin LA, Walt JG, Chiang T, Katz LM, Dolgitser M, Doyle JJ, Stern LS.
    Ophthalmology; 2007 Jul; 114(7):1241-7. PubMed ID: 17306876
    [Abstract] [Full Text] [Related]

  • 44. Patterns of treatment and costs associated with transfusion burden in patients with myelodysplastic syndromes.
    DeZern AE, Binder G, Rizvi S, Corvino FA, Arikian SR, Surinach A, Lee J, Smith BD.
    Leuk Lymphoma; 2017 Nov; 58(11):2649-2656. PubMed ID: 28482722
    [Abstract] [Full Text] [Related]

  • 45. Analysis of the impact and burden of illness of adult chronic ITP in the US.
    Saleh MN, Fisher M, Grotzinger KM.
    Curr Med Res Opin; 2009 Dec; 25(12):2961-9. PubMed ID: 19835465
    [Abstract] [Full Text] [Related]

  • 46. Continuity of care: is it cost effective?
    Raddish M, Horn SD, Sharkey PD.
    Am J Manag Care; 1999 Jun; 5(6):727-34. PubMed ID: 10538452
    [Abstract] [Full Text] [Related]

  • 47. Reducing the number of emergency department visits and costs associated with anxiety: a randomized controlled study.
    Kolbasovsky A, Reich L, Futterman R, Meyerkopf N.
    Am J Manag Care; 2007 Feb; 13(2):95-102. PubMed ID: 17286529
    [Abstract] [Full Text] [Related]

  • 48. Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence.
    Balu S, Simko RJ, Quimbo RM, Cziraky MJ.
    Curr Med Res Opin; 2009 Nov; 25(11):2765-75. PubMed ID: 19785511
    [Abstract] [Full Text] [Related]

  • 49. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
    Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB.
    Vaccine; 2007 Jun 28; 25(27):5086-96. PubMed ID: 17544181
    [Abstract] [Full Text] [Related]

  • 50. Incremental direct expenditure of treating asthma in the United States.
    Kamble S, Bharmal M.
    J Asthma; 2009 Feb 28; 46(1):73-80. PubMed ID: 19191142
    [Abstract] [Full Text] [Related]

  • 51. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MF, Tierce J, Reed M, Lipton RB.
    Headache; 2009 Apr 28; 49(4):498-508. PubMed ID: 19245386
    [Abstract] [Full Text] [Related]

  • 52. The economic burden of gout on an employed population.
    Brook RA, Kleinman NL, Patel PA, Melkonian AK, Brizee TJ, Smeeding JE, Joseph-Ridge N.
    Curr Med Res Opin; 2006 Jul 28; 22(7):1381-9. PubMed ID: 16834837
    [Abstract] [Full Text] [Related]

  • 53. The impact of psoriasis on health care costs and patient work loss.
    Fowler JF, Duh MS, Rovba L, Buteau S, Pinheiro L, Lobo F, Sung J, Doyle JJ, Swensen A, Mallett DA, Kosicki G.
    J Am Acad Dermatol; 2008 Nov 28; 59(5):772-80. PubMed ID: 19119095
    [Abstract] [Full Text] [Related]

  • 54. Economic burden and co-morbidities of atrial fibrillation in a privately insured population.
    Wu EQ, Birnbaum HG, Mareva M, Tuttle E, Castor AR, Jackman W, Ruskin J.
    Curr Med Res Opin; 2005 Oct 28; 21(10):1693-9. PubMed ID: 16238910
    [Abstract] [Full Text] [Related]

  • 55. Cost implications of IV versus oral anti-angiogenesis therapies in patients with advanced renal cell carcinoma: retrospective claims database analysis.
    Duh MS, Dial E, Choueiri TK, Fournier AA, Antras L, Rodermund D, Neary MP, Oh WK.
    Curr Med Res Opin; 2009 Aug 28; 25(8):2081-90. PubMed ID: 19586325
    [Abstract] [Full Text] [Related]

  • 56. The health and economic burden of genital warts in a set of private health plans in the United States.
    Insinga RP, Dasbach EJ, Myers ER.
    Clin Infect Dis; 2003 Jun 01; 36(11):1397-403. PubMed ID: 12766834
    [Abstract] [Full Text] [Related]

  • 57. Vesicoureteral reflux and ureteroceles.
    Pohl HG, Joyce GF, Wise M, Cilento BG.
    J Urol; 2007 May 01; 177(5):1659-66. PubMed ID: 17437779
    [Abstract] [Full Text] [Related]

  • 58. Healthcare cost attributable to recently-diagnosed breast cancer in a privately-insured population in the United States.
    Fu AZ, Jhaveri M.
    J Med Econ; 2012 May 01; 15(4):688-94. PubMed ID: 22397589
    [Abstract] [Full Text] [Related]

  • 59. The economic impact of dementia in Belgium: results of the National Dementia Economic Study (NADES).
    Scuvee-Moreau J, Kurz X, Dresse A, National Dementia Economic Study Group.
    Acta Neurol Belg; 2002 Sep 01; 102(3):104-13. PubMed ID: 12400248
    [Abstract] [Full Text] [Related]

  • 60. The impact of nonreferral outpatient co-payment on medical care utilization and expenditures in Taiwan.
    Chen LC, Schafheutle EI, Noyce PR.
    Res Social Adm Pharm; 2009 Sep 01; 5(3):211-24. PubMed ID: 19733822
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.